XPA Human shRNA Plasmid Kit (Locus ID 7507)
CAT#: TR308346
XPA - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 1 publication. |
Product images
![](https://cdn.origene.com/img/defaults-img.jpg)
经常一起买 (2)
Specifications
Product Data | |
Product Name | XPA Human shRNA Plasmid Kit (Locus ID 7507) |
Locus ID | 7507 |
UniProt ID | P23025 |
Synonyms | XP1; XPAC |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | XPA - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 7507). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_000380, NR_027302, NM_001354975, NR_149091, NR_149092, NR_149093, NR_149094, NM_000380.1, NM_000380.2, NM_000380.3, BC014965, BC014965.1, NM_000380.4 |
Summary | This gene encodes a zinc finger protein plays a central role in nucleotide excision repair (NER), a specialized type of DNA repair. NER is responsible for repair of UV radiation-induced photoproducts and DNA adducts induced by chemical carcinogens and chemotherapeutic drugs. The encoded protein interacts with DNA and several NER proteins, acting as a scaffold to assemble the NER incision complex at sites of DNA damage. Mutations in this gene cause Xeroderma pigmentosum complementation group A (XP-A), an autosomal recessive skin disorder featuring hypersensitivity to sunlight and increased risk for skin cancer. [provided by RefSeq, Aug 2017] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
Downregulated XPA promotes carcinogenesis of bladder cancer via impairment of DNA repair
,Zhi, Y;Ji, H;Pan, J;He, P;Zhou, X;Zhang, H;Zhou, Z;Chen, Z;,
Tumour Biol
,PubMed ID 28222669
[XPA]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...